## MKTX: MarketAxess Holdings Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 0.7% below STRENGTH zone (3.0-6.0%); PEG 2.47 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.9% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($173.22)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. (MKTX) as a Liquidity Pulse for Institutional Tactics**
- Source: Stock Traders Daily | 20251221T210400 | Somewhat-Bullish | Relevance: 100%
- This article provides an in-depth analysis of Marketaxess Holdings Inc. (NASDAQ: MKTX), highlighting a mixed sentiment alignment leading to potential choppiness across various trading horizons. It details several AI-generated trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The report also emphasizes an exceptional 35.6:1 risk-reward setup targeting a 10.3% gain against a minimal 0.3% risk.

**2. 8,312 Shares in MarketAxess Holdings Inc. $MKTX Bought by Matauro LLC**
- Source: MarketBeat | 20251220T130811 | Somewhat-Bullish | Relevance: 100%
- Matauro LLC recently acquired 8,312 shares of MarketAxess Holdings Inc. in the third quarter, valued at approximately $1.45 million, joining other institutional investors increasing their stakes. The company maintains a "Hold" rating from analysts with a consensus price target of $205.27. MarketAxess reported an EPS beat but a slight revenue miss, trading around $178.78, and pays a quarterly dividend of $0.76.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Morgan Stanley | $204 | $209 | -2% |
| 2025-12-17 | Argus Research | $205 | $212 | -3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Morgan Stanley | main | Equal-Weight |
| 2025-12-17 | Argus Research | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 2 ($0.02M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 50.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (-11.6%)
- Primecap Management : 6.0% (+66.6%)
- FMR, LLC: 5.8% (-8.1%)
- Van Eck Associates C: 5.2% (+6.5%)
- Blackrock Inc.: 5.0% (-30.2%)

### Key Risks

1. Long-term trend broken: trading 8.0% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.47 elevated, pricing in significant growth expectations. Forward P/E 22.1x attractive for 40% earnings growth. Quality metrics strong (ROA 11%, margin 26%). Balance sheet: strong liquidity (2.5x), low leverage (D/E 0.45). Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $6.8B |
| Beta | 0.99 |
| 52W Range | $156.17 - $232.84 |
| Short Interest | 4.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.47 |
| Forward P/E | 22.1 |
| Current P/E | 30.9 |
| YoY Growth | 40.1% |
| EPS Direction | FALLING |

### Technicals

MRS_10 deteriorating from 5.5% to 0.7% (-4.9% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.4pp (needs >3.0% for momentum thesis). MRS_5 (-1.0%) diverging from MRS_10 - short-term weakness emerging. Below SMA200 (0.92x), long-term trend not supportive. MACD histogram positive (1.28), confirming momentum. OFD pattern: +SLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.65% (CS: 64) | Neutral |
| RSI_14 | 65.4 | Neutral |
| MACD Histogram | 1.28 | Bullish |
| vs SMA20 | 1.059x | Above |
| vs SMA50 | 1.071x | Above |
| vs SMA200 | 0.920x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $181.18
- **Stop Loss:** $173.22 (4.4% risk)
- **Target:** $189.14 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 113
- **Position Value:** $20,473.34
- **Portfolio %:** 20.47%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-05 (Est: $1.71)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.68 | $1.84 | +9.5% |
| 2025Q2 | $1.96 | $1.91 | -2.6% |
| 2025Q1 | $1.81 | $0.40 | -77.9% |
| 2024Q4 | $1.68 | $1.73 | +3.2% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*